U.S. Pharmaceuticals Spend $8 Billion Annually in R&D Conducted Overseas - New Clintelligence® Alignment Module Advances Global Management
Pharmaceutical Industry Embraces Business Intelligence Tools to Manage Challenges of Culture, Regulation, and Patient Population Variances in their Global Development Programs
KENILWORTH, N.J., June 12 / -- 3C Company, Inc. (http://www.3cpharma.com/), a leading provider of Business Performance Optimization (BPO) solutions to the Life Sciences Industry, announces today the release of a new module to its highly successful Clintelligence® Business Intelligence Solution.
"There is no question that we must expand our research programs into new areas of the world, to ensure that patients in less exposed parts of the world have the benefits of being part of the drug development process," states the Executive Director of Global Clinical Research Operations at a Top 5 ranked Global Pharmaceutical. "This means taking on the challenges of placing these trials in areas that have different regulatory environments, different procedures and sometimes very different patient treatment regimens. These all add complexity to the management of a schedule and add risk to our goal of achieving FDA approval of our products in a timely and efficient manner."
"Where a drug is invented and where it is manufactured is much less critical than where research patients are located," explains Karen Briegs, a Sr. Director at 3C. "Conducting research in regions that have different rules of the game requires careful planning and close monitoring to avoid costly delays. We've addressed this complexity by creating an entire module within Clintelligence that focuses on the activities that occur on a global basis, and that highlights at a country-by-country level any risks in real-time. This is a significant addition to the product for any organization engaged in global research."
About Clintelligence®
Clintelligence® is the only commercially available Pharmaceutical Business Intelligence product that covers all of the critical topics across Research and Development (R&D). Clintelligence® uses maps, graphs, reports and analytical modules in an interactive, customizable web-portal format for easily understandable and actionable information. Clintelligence® leverages industry standard technology components and can be implemented rapidly in any sized company.
For more information on Clintelligence® go to www.clintelligence.com/ .
Source: 3C Company, Inc.
CONTACT: Karen Briegs, Director of Marketing of 3C Company, Inc.,
908-259-1101, kbriegs@3cpharma.com
Web site: http://www.3cpharma.com/
http://www.clintelligence.com/
